Cerebrovascular Diseases Journal

Overview
Identity
View All

publication venue for

Cost of Hospitalization for Stroke in a Low-Middle Income Country: Findings from a Public Tertiary Hospital in the Philippines 2019
Safety and Clinical Outcome of Good-Grade Aneurysmal Subarachnoid Hemorrhage in Non-Intensive Care Units 2019
Effect of a toolkit on physical therapists implementation of an evidence-informed approach to using the 10-metre and 6-minute walk tests post stroke - a before and after study 2017
Usage and perceptions of iWalk - A mobile application designed to facilitate physical therpists uptake of the 10-metre and 6-minute walk test post stroke 2017
NAVIGATE ESUS: Multicenter, Randomized, Double-Blind, Phase III Trial of Rivaroxaban vs. Aspirin for the Prevention of Recurrent Stroke and Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source 2015
Sporadic cerebral amyloid angiopathy with and without intracerebral haemorrhage: evidence for distinct disease phenotypes 2015
Abnormal left ventricular geometry in lacunar stroke: Spectrum, prevalence and prognosis in the SPS3 Trial 2014
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease: An individual patient data meta-analysis 2014
Cognitive Impairment in Spanish-speaking Patients with Recent Lacunar Stroke: The SPS3 Trial 2014
Depression and Apathy Are Related to Burden of Microvascular Lesions in Cerebral Amyloid Angiopathy 2014
Effect of Blood Pressure Lowering on Cognition in Patients with Lacunar Stroke. The Secondary Prevention of Small Subcortical Strokes (SPS3) trial. 2014
Inflammatory Biomarkers, Cerebral Microbleeds, and Small Vessel Disease: The Framingham Heart Study 2014
Matrix Metalloproteinases and Cerebral Microbleeds: The Framingham Heart Study. 2014
Predictors of Hypertensive Changes on MRI in a Young Stroke Population 2014
Stroke unit services across 30 countries; a survey of participants in the INTERSTROKE study 2014
The Yin and Yang of Superficial Siderosis and Microbleeds in Cerebral Amyloid Angiopathy 2014
Classification, Prognosis and Response to Treatment of Lacunar Strokes Based on Likely Pathogenic Mechanism: The SPS3 Trial 2013
Clinical Outcomes of Patients with Previous Transient Ischaemic Attack or Stroke - a Subgroup Analysis of the Long-Term Extension of Dabigatran in Patients with Atrial Fibrillation (RELY-ABLE) Study 2013
Effects of Blood Pressure Targets in Patients with Recent Lacunar Stroke: Results of the SPS3 Trial 2013
Enlarge Perivascular Spaces in in Lacunar Stroke Patients; Results of The SPS3 trial 2013
Global availability of stroke unit care; a survey of participants in the INTERSTROKE study 2013
Patient Age Linked to Prolonged Door-to-Needle Times in Stroke Thrombolysis 2013
Recurrent Events and Mortality Among Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the RE-LY Trial 2013
The Impact of Blood Pressure Variability on Stroke Recurrence: The SPS3 trial 2013
Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation: Analysis in Asian Population in RE-LY Trial 2012
Ticlopidine and Clopidogrel in Secondary Stroke Prevention 1997
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. 1-1. 2024
Erratum. 53:363-363. 2024
Endotracheal Intubation and In-Hospital Mortality after Intracerebral Hemorrhage. 45:270-278. 2018
Stroke Prenotification Is Associated with Shorter Treatment Times for Warfarin-Associated Intracerebral Hemorrhage. 36:383-387. 2013
Cerebral Microbleeds: Histopathological Correlation of Neuroimaging. 32:528-534. 2011
MRI-Based Neuroanatomical Predictors of Dysphagia after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. 32:1-10. 2011
Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin. 32:22-27. 2011
Effect of Long-Term Homocysteine Reduction with B Vitamins on Arterial Wall Inflammation Assessed by Fluorodeoxyglucose Positron Emission Tomography: A Randomised Double-Blind, Placebo-Controlled Trial. 27:259-265. 2009
Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). 23:368-380. 2007
Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments. 22:286-293. 2006
Sustained Homocysteine-Lowering Effect over Time of Folic Acid-Based Multivitamin Therapy in Stroke Patients despite Increasing Folate Status in the Population. 19:110-116. 2005
Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003). 17:91-92. 2004
Erratum. 17:91-92. 2004
Incident Cerebrovascular Disease in Rural and Urban Alberta. 17:72-78. 2004
The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke. 13:120-126. 2002
Closing Remarks. 4:47-47. 1994

has subject area

1103 Clinical Sciences (FoR)
1109 Neurosciences (FoR)
Neurology & Neurosurgery (Science Metrix)